share_log

九州通(600998.SH):子公司获得化学原料药上市申请批准通知书

Jointown Pharmaceutical Group (600998.SH): A subsidiary has received the approval notice for the listing application of Chemical Raw Materials.

Gelonghui Finance ·  Dec 20, 2024 17:17

On December 20, 2023, Jointown Pharmaceutical Group (600998.SH) announced that its holding subsidiary, Peking Jingfeng Pharmaceutical (ShanDong) Co., Ltd., received the "Approval Notice for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration on December 20, 2024, granting approval for the listing application of L-Malic Acid. L-Malic Acid is widely used in drugs for liver dysfunction, uremia, hypertension, cancer, heart disease, etc. Adding L-Malic Acid to medications can enhance their stability and promote absorption and Diffusion in the body, while L-Malic Acid can also reduce the toxic effects of anticancer drugs on normal cells.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment